After weathering the COVID-19 pandemic for more than a year, Taiwan has since early last month been hit by a wave of local infections. Before then, few people were concerned about vaccines, but the issue has suddenly become the focus of public attention. The urgency of obtaining vaccines has been much discussed, but many do not understand the peculiarities of the vaccine industry, or international vaccine supply and demand amid a pandemic.
Taiwan’s epidemic prevention policy over the past four decades has been oriented toward public health — from the control and prevention of hepatitis B in the early 1980s and the local development of an avian influenza vaccine in the early 2000s to the development of enterovirus vaccines — with emergency situations receiving temporary policy support, but support for vaccine development ebbed as the epidemics subsided.
Over the past decade, there have only been a handful of domestic vaccine manufacturers, but they have played an important role in public health by supplying influenza vaccines. Two domestic enterovirus vaccines even entered phase 3 clinical trials.
Taiwan’s excellent performance at disease prevention since the beginning of last year had given Taiwanese peace of mind as they went about their daily lives, and the recent outbreak has led to the public demanding that the government obtain an adequate supply of vaccine doses.
The market for COVID-19 vaccines is still a seller’s market, with each major international player — Europe and the US on the one hand, and China and Russia on the other — following its own approach. Taiwan has struggled to find a vaccine source in the European and US supply chain.
However, those not involved in the negotiations cannot understand the hardships faced by officials. Once the outbreak has been effectively controlled and the nation’s vaccine needs softened, the government should establish a vaccine industry policy based on national security.
The Taiwanese vaccine market, with a population of 24 million, is not large enough to support an internationally competitive vaccine industry. Even in South Korea, whose population is more than double Taiwan’s, vaccines at this stage are produced by contract manufacturers for international pharmaceutical companies.
Local vaccine manufacturers Medigen Vaccine Biologics and United Biomedical have conducted phase 2 clinical trials — some talk of them as phase 2/3 clinical trials — of a COVID-19 vaccine, with more than 3,000 participants. The nation would hopefully give them heartfelt support to avoid relying on foreign sources for vaccines in a future pandemic.
The vaccine industry must be positioned as one of the industries crucial to national security, and government policies must provide the industry with subsidies or tax incentives, as well as a guarantee of at least one-third to one-half of the domestic market to support normal production.
Regarding the need for vaccines, as the nation seeks sources, it should also pay attention to the nature of the vaccine industry.
The process of manufacturing vaccines at any pharmaceutical company follows a specific plan and timetable. There are basic elements that must not be ignored, such as quantity, batch number, batch production records, the original quality control inspection and qualification documents, and the cold chain records of the transportation process, among others.
Close cooperation with the Central Epidemic Command Center is still required after a vaccine shipment arrives at an airport, in the subsequent transportation, storage, distribution and administration stages. Perhaps a batch-by-batch emergency approach could be adopted, instead of being bound by administrative details such as, for example, the applicant’s qualifications.
At this time of urgent need, the Food and Drug Administration ensures that the vaccine documentation confirms the quality and safety of the doses in accordance with the Regulations of the Lot Release Procedures for Biologics (生物藥品檢驗封緘作業辦法). Because of the urgency involved, the release procedure — including testing items such as sterility and acute toxicity — should be synchronized with the distribution and transportation of the doses.
Although the release of a vaccine lot must comply with regulations, its execution should be more flexible in these extraordinary times. The batch quality control release document issued by the original manufacturer is sufficient to confirm the quality of a batch, and the inspection typically conducted only drags out the administrative process.
The release policy should be governed by a different mindset, and a batch-by-batch approach that fast-tracks the validation process should be adopted to promote a timely vaccine supply.
Huang Weng-foung is an adjunct professor at National Yang Ming Chiao Tung University and a former director-general of the Ministry of Health and Welfare’s Bureau of Pharmaceutical Affairs.
Translated by Perry Svensson
There is a modern roadway stretching from central Hargeisa, the capital of Somaliland in the Horn of Africa, to the partially recognized state’s Egal International Airport. Emblazoned on a gold plaque marking the road’s inauguration in July last year, just below the flags of Somaliland and the Republic of China (ROC), is the road’s official name: “Taiwan Avenue.” The first phase of construction of the upgraded road, with new sidewalks and a modern drainage system to reduce flooding, was 70 percent funded by Taipei, which contributed US$1.85 million. That is a relatively modest sum for the effect on international perception, and
At the end of last year, a diplomatic development with consequences reaching well beyond the regional level emerged. Israeli Prime Minister Benjamin Netanyahu declared Israel’s recognition of Somaliland as a sovereign state, paving the way for political, economic and strategic cooperation with the African nation. The diplomatic breakthrough yields, above all, substantial and tangible benefits for the two countries, enhancing Somaliland’s international posture, with a state prepared to champion its bid for broader legitimacy. With Israel’s support, Somaliland might also benefit from the expertise of Israeli companies in fields such as mineral exploration and water management, as underscored by Israeli Minister of
When former president Tsai Ing-wen (蔡英文) first took office in 2016, she set ambitious goals for remaking the energy mix in Taiwan. At the core of this effort was a significant expansion of the percentage of renewable energy generated to keep pace with growing domestic and global demands to reduce emissions. This effort met with broad bipartisan support as all three major parties placed expanding renewable energy at the center of their energy platforms. However, over the past several years partisanship has become a major headwind in realizing a set of energy goals that all three parties profess to want. Tsai
An elderly mother and her daughter were found dead in Kaohsiung after having not been seen for several days, discovered only when a foul odor began to spread and drew neighbors’ attention. There have been many similar cases, but it is particularly troubling that some of the victims were excluded from the social welfare safety net because they did not meet eligibility criteria. According to media reports, the middle-aged daughter had sought help from the local borough warden. Although the warden did step in, many services were unavailable without out-of-pocket payments due to issues with eligibility, leaving the warden’s hands
RSS